TC
ZSPH

TFS Capital’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

TFS Capital’s Portfolio ZSPH Stock Details ZSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,391
Closed -$649K – 1200
2015
Q2 		$649K Buy
+12,391
New +$610K 0.06% 445

Other funds holding ZSPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TFS Capital's ZSPH Position: Q3 2015 in Review

TFS Capital sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q3 2015, closing a stake of 12,391 shares — an estimated $649K sold.

TFS Capital first reported a position in ZSPH in Q2 2015 and held it in 1 quarter. The position peaked at $649K in Q2 2015. 124 funds tracked by Wall St. Rank hold ZSPH as of Q3 2015.

  • TFS Capital reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q3 2015 after selling out during the quarter.
  • TFS Capital sold 12,391 ZS PHARMA INC COMS TK (DE) shares in Q3 2015, an estimated $649K.
  • TFS Capital first reported a position in ZS PHARMA INC COMS TK (DE) in Q2 2015 and held it in 1 quarter.
  • TFS Capital's ZS PHARMA INC COMS TK (DE) position peaked at $649K in Q2 2015.
  • 124 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q3 2015.

Based on TFS Capital's 13F filing for Q3 2015, filed 3 Nov 2015.